Literature DB >> 17629278

A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases.

Weiwei Li1, Jacqueline L Blankman, Benjamin F Cravatt.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17629278     DOI： 10.1021/ja073650c

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN： 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  81 in total

1.  Discovery and optimization of sulfonyl acrylonitriles as selective, covalent inhibitors of protein phosphatase methylesterase-1.

Authors:  Daniel A Bachovchin; Andrea M Zuhl; Anna E Speers; Monique R Wolfe; Eranthie Weerapana; Steven J Brown; Hugh Rosen; Benjamin F Cravatt
Journal:  J Med Chem       Date:  2011-06-30       Impact factor: 7.446

2.  A potent and selective inhibitor of KIAA1363/AADACL1 that impairs prostate cancer pathogenesis.

Authors:  Jae Won Chang; Daniel K Nomura; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2011-04-22

3.  Competitive activity-based protein profiling identifies aza-β-lactams as a versatile chemotype for serine hydrolase inhibition.

Authors:  Andrea M Zuhl; Justin T Mohr; Daniel A Bachovchin; Sherry Niessen; Ku-Lung Hsu; Jacob M Berlin; Maximilian Dochnahl; María P López-Alberca; Gregory C Fu; Benjamin F Cravatt
Journal:  J Am Chem Soc       Date:  2012-03-08       Impact factor: 15.419

Review 4.  The pharmacological landscape and therapeutic potential of serine hydrolases.

Authors:  Daniel A Bachovchin; Benjamin F Cravatt
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

5.  Abundance- and Activity-Based Proteomics in Platelet Biology.

Authors:  Stephen P Holly; Xian Chen; Leslie V Parise
Journal:  Curr Proteomics       Date:  2011-10       Impact factor: 0.837

Review 6.  Natural products as chemical probes.

Authors:  Erin E Carlson
Journal:  ACS Chem Biol       Date:  2010-07-16       Impact factor: 5.100

7.  Strategies for discovering and derisking covalent, irreversible enzyme inhibitors.

Authors:  Douglas S Johnson; Eranthie Weerapana; Benjamin F Cravatt
Journal:  Future Med Chem       Date:  2010-06       Impact factor: 3.808

8.  Chemoproteomic discovery of AADACL1 as a regulator of human platelet activation.

Authors:  Stephen P Holly; Jae Won Chang; Weiwei Li; Sherry Niessen; Ryan M Phillips; Raymond Piatt; Justin L Black; Matthew C Smith; Yacine Boulaftali; Andrew S Weyrich; Wolfgang Bergmeier; Benjamin F Cravatt; Leslie V Parise
Journal:  Chem Biol       Date:  2013-08-29

9.  Application of activity-based protein profiling to study enzyme function in adipocytes.

Authors:  Andrea Galmozzi; Eduardo Dominguez; Benjamin F Cravatt; Enrique Saez
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

10.  The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome.

Authors:  Gwynneth Thomas; Jenna L Betters; Caleb C Lord; Amanda L Brown; Stephanie Marshall; Daniel Ferguson; Janet Sawyer; Matthew A Davis; John T Melchior; Lawrence C Blume; Allyn C Howlett; Pavlina T Ivanova; Stephen B Milne; David S Myers; Irina Mrak; Vera Leber; Christoph Heier; Ulrike Taschler; Jacqueline L Blankman; Benjamin F Cravatt; Richard G Lee; Rosanne M Crooke; Mark J Graham; Robert Zimmermann; H Alex Brown; J Mark Brown
Journal:  Cell Rep       Date:  2013-10-03       Impact factor: 9.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.